• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » ADHD Prevalence in the US Black Population

ADHD Prevalence in the US Black Population

July 14, 2021
Thomas Jordan, MD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Thomas Jordan, MD. Dr. Jordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Cénat JM et al, JAMA Psychiatry 2021;78(1):21–28

STUDY TYPE: Meta-analysis

In the general population, the reported prevalence of ADHD is about 10%, with estimates varying from around 5% to 15%. Black individuals are typically underrepresented in these studies, and with fewer data, it is no surprise that the estimates are less precise, with an estimated prevalence of 5% to over 20%. This study tried to improve the accuracy of prevalence measures of ADHD among Black individuals as well as identify specific risk factors for ADHD in this population.

The authors found 21 US articles published from 1979 through 2019 with 24 independent samples or subsamples of Black people. Most (13) included both children and adolescents. Eight samples included only children, one included only adolescents, and two included only adults. From these studies, the authors conducted a meta-analysis and computed a pooled ADHD prevalence of 14.5% (95% CI, 10.64%–19.56%). When only the samples of children and adolescents were included, the prevalence was 13.9%, which was not significantly different.

Older children (10–17 years) were more likely to receive an ADHD diagnosis, as were males. Males also received more prescriptions for ADHD than females. In at-risk populations like juvenile offenders, Black youth were less likely to be diagnosed with ADHD. Interestingly, Black parents were less likely to report ADHD symptoms in their children while teachers reported more symptoms. Low socioeconomic status was a risk factor for ADHD in Black individuals, but high socioeconomic status was not a protective factor against ADHD as it is in white individuals.

CCPR’S Take
This study shows that Black Americans are more likely to meet diagnostic criteria for ADHD than the general population, with a prevalence of about 14% vs about 10%. It’s not clear what drives this disparity, although an increased tendency for teachers to identify ADHD symptoms in Black children, lower socioeconomic status, as well as culturally determined biases in the ADHD construct itself might be factors. These data contradict the DSM-5, which indicates that Blacks have a lower rate of ADHD, and this should encourage us to be more vigilant in screening and treating our Black patients for this condition.
Child Psychiatry
KEYWORDS adhd black-youth diagnosis disparities prevalence
    Thomas Jordan, MD.

    Methylphenidate Max Dosing

    More from this author
    www.thecarlatreport.com
    Issue Date: July 14, 2021
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Substance Use in Children and Adolescents, CCPR, July/August/September 2021
    Teen Drinking: Risks and Responses
    Addressing the Hazards of Performance-Enhancing Substances
    Citalopram Plus Stimulants for Chronic Irritability?
    SSRIs vs SNRIs in Pediatric Anxiety Disorders: Which Are More Tolerable?
    Is It Time for an Online Tantrum Tool?
    ADHD Prevalence in the US Black Population
    Note From the Editor-in-Chief
    Reading Research: Details Matter
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.